Pluto Biosciences, Inc

GSE150069 (human): Development and Application of a Transcriptomic Signature of Bioactivation in an Advanced In Vitro Liver Model to Reduce Drug-induced Liver Injury Risk Early in the Pharmaceutical Pipeline

Bulk RNA sequencing

Translation of NRF1/NRF2-mediated liver tissue biomarkers to an in vitro assay using an advanced micropatterned co-culture system (HEPATOPAC) with primary hepatocytes from male Wistar-Hannover rats or humans SOURCE: Alexei,A,PodtelezhnikovWP53B-120 Merck & Co., Inc.

View this experiment on Pluto Biosciences, Inc